2. Search Result
Search Result
Results for "

Sympathomimetic activity

" in MedChemExpress (MCE) Product Catalog:

22

Inhibitors & Agonists

3

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-A0252
    Bupranolol

    		Adrenergic Receptor Inflammation/Immunology Cancer
    Bupranolol is an orally active, competitive and non-selective β-adrenoceptor antagonist without intrinsic sympathomimetic activity .
    Bupranolol
  • HY-103214
    Bucindolol

    		Adrenergic Receptor Cardiovascular Disease Endocrinology
    Bucindolol is a β1-adrenergic receptor blocker, with intrinsic sympathomimetic activity, used in the research of heart failure .
    Bucindolol
  • HY-B1276
    Metaproterenol hemisulfate

    Metaproterenol sulfate

    		 Adrenergic Receptor Cardiovascular Disease Inflammation/Immunology Endocrinology
    Metaproterenol hemisulfate (Orciprenaline hemisulfate) is a direct-acting sympathomimetic and a β2-adrenergic receptor (β2AR) agonist with an IC50 of 68 nM. Metaproterenol hemisulfate also has anti-inflammatory activity .
    Metaproterenol hemisulfate
  • HY-106684
    Ridazolol

    		Adrenergic Receptor Cardiovascular Disease
    Ridazolol is a β-adrenergic receptor (βAR) antagonist. Ridazolol exhibits a high degree of selectivity for β-1 adrenergic receptor (β1AR) and possesses moderate intrinsic sympathomimetic activity (ISA). Ridazolol can competitively antagonize the relaxation effects induced by isoproterenol. Ridazolol is utilized in the research of cardiovascular diseases .
    Ridazolol
  • HY-106684A
    Ridazolol hydrochloride

    		Adrenergic Receptor Cardiovascular Disease
    Ridazolol hydrochloride is a β-adrenergic receptor (βAR) antagonist. Ridazolol hydrochloride exhibits a high degree of selectivity for β-1 adrenergic receptor (β1AR) and possesses moderate intrinsic sympathomimetic activity (ISA). Ridazolol hydrochloride can competitively antagonize the relaxation effects induced by isoproterenol. Ridazolol hydrochloride is utilized in the research of cardiovascular diseases .
    Ridazolol hydrochloride
  • HY-U00019
    Pamatolol

    		Adrenergic Receptor Cardiovascular Disease Endocrinology
    Pamatolol is a cardioselective beta-adrenoceptor antagonist without sympathomimetic activity.
    Pamatolol
  • HY-121045
    Bunitrolol

    KO 1366

    		 Adrenergic Receptor Cardiovascular Disease
    Bunitrolol is a beta-adrenergic antagonist. Bunitrolol has intrinsic sympathomimetic activity. Bunitrolol can be used for the research of ischemic myocardium .
    Bunitrolol
  • HY-A0252R
    Bupranolol (Standard)

    		Adrenergic Receptor Inflammation/Immunology Cancer
    Bupranolol (Standard) is the analytical standard of Bupranolol. This product is intended for research and analytical applications. Bupranolol is an orally active, competitive and non-selective β-adrenoceptor antagonist without intrinsic sympathomimetic activity .
    Bupranolol (Standard)
  • HY-B1276A
    Metaproterenol

    Orciprenaline

    		 Adrenergic Receptor Cardiovascular Disease Inflammation/Immunology Endocrinology
    Metaproterenol (Orciprenaline) is a direct-acting sympathomimetic and a β2-adrenergic receptor (β2AR) agonist with an IC50 of 68 nM. Metaproterenol also has anti-inflammatory activity .
    Metaproterenol
  • HY-101434A
    Cetamolol hydrochloride

    AI-27303 hydrochloride; ICI-72222 hydrochloride

    		 Others Others
    Cetamolol hydrochloride is classified as a potent β1-blocker with intrinsic sympathomimetic activity and cardioselectivity. Low and medium doses of Cetamolol and Atenolol produce a more prolonged inhibitory effect than the same doses of Propranolol and Dexpropranolol.
    Cetamolol hydrochloride
  • HY-106667
    DL 071IT

    		Adrenergic Receptor Cardiovascular Disease Endocrinology
    DL 071IT is a potent non-selective beta-adrenergic receptor blocker. DL 071IT exhibits intrinsic sympathomimetic activity and weak membrane stabilizing activity. DL 071IT reduces exercise heart rate and systolic blood pressure, and even significantly lowers resting heart rate .
    DL 071IT
  • HY-105856
    Thozalinone

    		Others Neurological Disease
    Thozalinone also known as 5phenyl-2-dimethylamino-2-oxazolin-4-one, is an antidepressant with activity against Tetrabenazine. Thozalinone has unique properties distinguishing them from the sympathomimetic amines .
    Thozalinone
  • HY-B1276S
    Metaproterenol-d7 hemisulfate

    		Isotope-Labeled Compounds Adrenergic Receptor Cardiovascular Disease Inflammation/Immunology Endocrinology
    Metaproterenol-d7 (hemisulfate) is the deuterium labeled Metaproterenol hemisulfate. Metaproterenol hemisulfate (Orciprenaline hemisulfate) is a direct-acting sympathomimetic and a β2-adrenergic receptor (β2AR) agonist with an IC50 of 68 nM. Metaproterenol hemisulfate also has anti-inflammatory activity[1][2].
    Metaproterenol-d7 hemisulfate
  • HY-B1276R
    Metaproterenol hemisulfate (Standard)

    		Adrenergic Receptor Cardiovascular Disease Inflammation/Immunology Endocrinology
    Metaproterenol (hemisulfate) (Standard) is the analytical standard of Metaproterenol (hemisulfate). This product is intended for research and analytical applications. Metaproterenol hemisulfate (Orciprenaline hemisulfate) is a direct-acting sympathomimetic and a β2-adrenergic receptor (β2AR) agonist with an IC50 of 68 nM. Metaproterenol hemisulfate also has anti-inflammatory activity .
    Metaproterenol hemisulfate (Standard)
  • HY-100634
    4-Hydroxypropranolol hydrochloride

    (±)-4-hydroxy Propranolol hydrochloride

    		 Adrenergic Receptor Neurological Disease
    4-Hydroxypropranolol hydrochlorid is an active metabolite of Propranolol. 4-Hydroxypropranolol hydrochlorid is of comparable potency to Propranolol. 4-Hydroxypropranolol hydrochlorid inhibits β1- and β2-adrenergic receptors with pA2 values of 8.24 and 8.26, respectively. 4-Hydroxypropranolol hydrochlorid has intrinsic sympathomimetic activity, membrane stabilizing activity and potent antioxidant properties .
    4-Hydroxypropranolol hydrochloride
  • HY-B1116A
    Metaraminol

    (-)-Metaraminol; (-)-erythro-Metaraminol; (-)-m-Hydroxynorephedrine

    		 Others Neurological Disease
    Metaraminol ((-)-Metaraminol) is a sympathomimetic compound with activity that acts primarily at alpha-1 adrenergic receptors. Metaraminol is used to inhibit hypotension due to vasodilation, particularly in critically ill patients who do not respond well to volume resuscitation. Metaraminol may also be used as an adjunct to help improve cardiac contractility. The use of metaraminol may be supported by less evidence, but its effectiveness in specific situations remains of interest .
    Metaraminol
  • HY-100634S
    4-Hydroxypropranolol-d7 hydrochloride

    (±)-4-Hydroxy Propranolol-d7 hydrochloride

    		 Isotope-Labeled Compounds Adrenergic Receptor Neurological Disease
    4-Hydroxypropranolol-d7 (hydrochloride) is a deuterium labeled 4-Hydroxypropranolol hydrochloride. 4-Hydroxypropranolol hydrochlorid is an active metabolite of Propranolol, with potency comparable to Propranolol. 4-Hydroxypropranolol hydrochlorid inhibits β1- and β2-adrenergic receptors with pA2 values of 8.24 and 8.26, respectively. 4-Hydroxypropranolol hydrochlorid has intrinsic sympathomimetic activity, membrane stabilizing activity and potent antioxidant properties[1][2][3].
    4-Hydroxypropranolol-d7 hydrochloride
  • HY-100634SA
    4-Hydroxypropranolol-d7

    (±)-4-Hydroxy Propranolol-d7

    		 Isotope-Labeled Compounds Adrenergic Receptor Neurological Disease
    4-Hydroxypropranolol-d7 is the deuterium labeled 4-Hydroxypropranolol hydrochloride. 4-Hydroxypropranolol hydrochlorid is an active metabolite of Propranolol. 4-Hydroxypropranolol hydrochlorid is of comparable potency to Propranolol. 4-Hydroxypropranolol hydrochlorid inhibits β1- and β2-adrenergic receptors with pA2 values of 8.24 and 8.26, respectively. 4-Hydroxypropranolol hydrochlorid has intrinsic sympathomimetic activity, membrane stabilizing activity and potent antioxidant properties[1][2][3].
    4-Hydroxypropranolol-d7
  • HY-100634R
    4-Hydroxypropranolol hydrochloride (Standard)

    		Adrenergic Receptor Neurological Disease
    4-Hydroxypropranolol (hydrochloride) (Standard) is the analytical standard of 4-Hydroxypropranolol (hydrochloride). This product is intended for research and analytical applications. 4-Hydroxypropranolol hydrochlorid is an active metabolite of Propranolol. 4-Hydroxypropranolol hydrochlorid is of comparable potency to Propranolol. 4-Hydroxypropranolol hydrochlorid inhibits β1- and β2-adrenergic receptors with pA2 values of 8.24 and 8.26, respectively. 4-Hydroxypropranolol hydrochlorid has intrinsic sympathomimetic activity, membrane stabilizing activity and potent antioxidant properties .
    4-Hydroxypropranolol hydrochloride (Standard)
  • HY-B1562
    Bopindolol

    (±)-Bopindolol

    		 Adrenergic Receptor Renin 5-HT Receptor Cardiovascular Disease Neurological Disease
    Bopindolol ((±)-Bopindolol) is an orally active antagonist of β-adrenoceptors (ARs) with partial agonist activity. Bopindolol is non-selective for β1- and β2-ARs and has low affinity for β3-AR subtype. Bopindolol has intrinsic sympathomimetic as well as membrane stabilizing actions, inhibits renin secretion, and interacts with 5-HT receptors. Bopindolol is a proagent of Pindolol (HY-B0982). Bopindolol can be used for essential and renovascular hypertension research.
    Bopindolol
  • HY-B1562C
    Bopindolol fumarate

    (±)-Bopindolol fumarate

    		 Adrenergic Receptor Renin 5-HT Receptor Cardiovascular Disease Neurological Disease
    Bopindolol ((±)-Bopindolol) fumarate is an orally active antagonist of β-adrenoceptors (ARs) with partial agonist activity. Bopindolol fumarate is non-selective for β1- and β2-ARs and has low affinity for β3-AR subtype. Bopindolol fumarate has intrinsic sympathomimetic as well as membrane stabilizing actions, inhibits renin secretion, and interacts with 5-HT receptors. Bopindolol fumarate is a proagent of Pindolol (HY-B0982). Bopindolol fumarate can be used for essential and renovascular hypertension research.
    Bopindolol fumarate
  • HY-B1562B
    Bopindolol (malonate)

    (±)-Bopindolol (malonate)

    		 Adrenergic Receptor Renin 5-HT Receptor Cardiovascular Disease Neurological Disease
    Bopindolol ((±)-Bopindolol) malonate is an orally active antagonist of β-adrenoceptors (ARs) with partial agonist activity. Bopindolol malonate is non-selective for β1- and β2-ARs and has low affinity for β3-AR subtype. Bopindolol malonate has intrinsic sympathomimetic as well as membrane stabilizing actions, inhibits renin secretion, and interacts with 5-HT receptors. Bopindolol malonate is a proagent of Pindolol (HY-B0982). Bopindolol malonate can be used for essential and renovascular hypertension research.
    Bopindolol (malonate)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: